Steven Cohen’s Precision BioSciences DTIL Stock Holding History

Steven Cohen’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$111K	Sell	14,104 -21,489	-60%	-$151K	﹤0.01%	3681
2026 Q1	$196K	Buy	35,593 +5,986	+20%	+$27.6K	﹤0.01%	3534
2025 Q4	$123K	Buy	+29,607	New	+$168K	﹤0.01%	3716
2021 Q3	–	Sell	-3,847	Closed	-$1.45M	–	1084
2021 Q2	$1.45M	Buy	+3,847	New	+$1.16M	0.01%	766
2020 Q4	–	Sell	-8,520	Closed	-$1.57M	–	957
2020 Q3	$1.57M	Buy	+8,520	New	+$1.69M	0.01%	730

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Steven Cohen's DTIL Position: Q2 2026 in Review

Steven Cohen reduced its Precision BioSciences (DTIL) stake by 60% in Q2 2026, selling an estimated $151K and leaving 14,104 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #3681.

Steven Cohen first reported a position in DTIL in Q3 2020 and has held it in 5 quarters since. The position peaked at $1.57M in Q3 2020. 94 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Steven Cohen held 14,104 shares of Precision BioSciences worth $111K as of Q2 2026.
Steven Cohen sold 21,489 Precision BioSciences shares in Q2 2026, an estimated $151K.
Precision BioSciences made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3681 holding.
Steven Cohen first reported a position in Precision BioSciences in Q3 2020 and has held it in 5 quarters since.
Steven Cohen's Precision BioSciences position peaked at $1.57M in Q3 2020.
94 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.